Cargando…

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis

Neurochemical biomarkers are urgently sought in ALS. Metabolomic analysis of cerebrospinal fluid (CSF) using proton nuclear magnetic resonance ((1)H-NMR) spectroscopy is a highly sensitive method capable of revealing nervous system cellular pathology. The (1)H-NMR CSF metabolomic signature of ALS wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gray, Elizabeth, Larkin, James R., Claridge, Tim D. W., Talbot, Kevin, Sibson, Nicola R., Turner, Martin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720042/ https://www.ncbi.nlm.nih.gov/pubmed/26121274 http://dx.doi.org/10.3109/21678421.2015.1053490

Ejemplares similares

Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients
por: Joilin, Greig, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
por: Dreger, Marie, et al.
Publicado: (2022)

Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
por: CHEN, YAN, et al.
Publicado: (2016)

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
por: Costa, Júlia, et al.
Publicado: (2021)

Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes
por: Zhou, Jinxia, et al.
Publicado: (2023)

Sweet food preference in amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2017)

Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS
por: Wuolikainen, Anna, et al.
Publicado: (2011)

Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis
por: Fabes, Jeremy, et al.
Publicado: (2017)

Psychiatric disorders prior to amyotrophic lateral sclerosis
por: Turner, Martin R., et al.
Publicado: (2016)

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2020)

Defective cholesterol metabolism in amyotrophic lateral sclerosis
por: Abdel-Khalik, Jonas, et al.
Publicado: (2017)

Neurofilament markers in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
por: Shi, Jiaying, et al.
Publicado: (2021)

Myelin imaging in amyotrophic and primary lateral sclerosis
por: Kolind, Shannon, et al.
Publicado: (2013)

Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis
por: Menke, Ricarda A. L., et al.
Publicado: (2014)

Cerebrospinal fluid cytotoxicity in amyotrophic lateral sclerosis: a systematic review of in vitro studies
por: Ng Kee Kwong, Koy Chong, et al.
Publicado: (2020)

Amyotrophic lateral sclerosis: the complex path to precision medicine
por: Talbot, Kevin, et al.
Publicado: (2018)

Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients
por: Sass, Lucas R., et al.
Publicado: (2020)

Cerebrovascular injury as a risk factor for amyotrophic lateral sclerosis
por: Turner, Martin R, et al.
Publicado: (2016)

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex
por: Nakayama, Yui, et al.
Publicado: (2013)

Increased cerebrospinal fluid adenosine 5'-triphosphate in patients with amyotrophic lateral sclerosis
por: Nukui, Takamasa, et al.
Publicado: (2021)

Interplay of Metallome and Metabolome in Amyotrophic Lateral Sclerosis: A Study on Cerebrospinal Fluid of Patients Carrying Disease-Related Gene Mutations
por: Solovyev, Nikolay, et al.
Publicado: (2023)

Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function
por: Drannik, Anna, et al.
Publicado: (2017)

Monoaminergic and Kynurenergic Characterization of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Cerebrospinal Fluid and Serum
por: Janssens, Jana, et al.
Publicado: (2020)

Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression
por: Sol, Joaquim, et al.
Publicado: (2021)

Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis
por: Bäumer, Dirk, et al.
Publicado: (2014)

CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis
por: Evans, Matthew C, et al.
Publicado: (2014)

Measurement of cystatin C functional activity in the cerebrospinal fluid of amyotrophic lateral sclerosis and control subjects
por: Wilson, Meghan E, et al.
Publicado: (2013)

Evidence for Fungal Infection in Cerebrospinal Fluid and Brain Tissue from Patients with Amyotrophic Lateral Sclerosis
por: Alonso, Ruth, et al.
Publicado: (2015)

Adiponectin levels in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients: possible influence on neuroinflammation?
por: Bossolasco, Patrizia, et al.
Publicado: (2017)

Human Spinal Motor Neurons Are Particularly Vulnerable to Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients
por: Bräuer, Stefan, et al.
Publicado: (2020)

CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis
por: Thompson, Alexander G., et al.
Publicado: (2020)

Astroglia acquires a toxic neuroinflammatory role in response to the cerebrospinal fluid from amyotrophic lateral sclerosis patients
por: Mishra, Pooja-Shree, et al.
Publicado: (2016)

Longitudinal biomarkers in amyotrophic lateral sclerosis
por: Huang, Fen, et al.
Publicado: (2020)

Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach
por: Kumar, Alok, et al.
Publicado: (2013)

Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis
por: Joilin, Greig, et al.
Publicado: (2020)

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
por: Lu, Ching-Hua, et al.
Publicado: (2015)

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
por: Menke, R.A.L., et al.
Publicado: (2017)

Cronobacter sakazakii DNA Detection in Cerebrospinal Fluid of a Patient with Amyotrophic Lateral Sclerosis Mimic Syndrome
por: Piombo, Marianna, et al.
Publicado: (2015)

Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
por: Otake, Kentaro, et al.
Publicado: (2019)

Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis
por: Tokuda, Eiichi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_splff8k6iohlr8sv4l1tuse7b2